← Scroll for more →
Financial Statements — MBX
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 54.12 | 45.21 | 75.29 | 223.13 | 39.78 | 29.90 | 49.35 | 132.87 |
| Short-term Investments | 364.46 | 394.76 | 298.42 | 168.55 | 185.13 | 210.88 | 212.80 | 144.20 |
| Total Current Assets | 427.86 | 448.54 | 381.54 | 397.50 | 229.19 | 244.28 | 267.29 | 281.17 |
| Property, Plant & Equipment | 4.66 | 3.13 | 2.74 | 2.00 | 1.73 | 1.51 | 1.08 | 1.03 |
| Total Non-current Assets* | 8.05 | 4.17 | 3.61 | 2.57 | 2.33 | 1.65 | 1.25 | 1.23 |
| Total Assets | 435.91 | 452.70 | 385.14 | 400.08 | 231.52 | 245.93 | 268.54 | 282.40 |
| Accounts Payable | 4.36 | 6.97 | 2.98 | 3.77 | 5.76 | 4.25 | 5.34 | 5.00 |
| Total Current Liabilities | 23.66 | 14.57 | 15.50 | 12.06 | 11.76 | 10.48 | 11.05 | 10.92 |
| Total Non-current Liabilities* | 2.71 | 0.38 | 0.43 | 0.48 | 0.53 | 0.02 | 0.04 | 0.11 |
| Total Liabilities | 26.37 | 14.95 | 15.92 | 12.54 | 12.28 | 10.50 | 11.09 | 11.03 |
| Retained Earnings | (285.09) | (247.99) | (224.48) | (202.41) | (180.80) | (161.38) | (137.50) | (121.92) |
| Total Stockholder Equity | 409.54 | 437.76 | 369.22 | 387.54 | 219.24 | 235.42 | 257.44 | 271.37 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | 30.99 | 18.47 | 19.76 | 19.27 | 17.72 | 22.41 | 15.22 | 16.75 |
| Selling, General & Admin | 9.95 | 8.79 | 6.04 | 4.66 | 4.08 | 4.12 | 3.39 | 2.87 |
| Total Operating Expenses | 40.93 | 27.27 | 25.80 | 23.93 | 21.81 | 26.53 | 18.61 | 19.61 |
| Operating Income | (40.93) | (27.26) | (25.79) | (23.93) | (21.80) | (26.53) | (18.61) | (19.61) |
| Net Income | (37.09) | (23.52) | (22.06) | (21.62) | (19.41) | (23.88) | (15.59) | (18.14) |
| Basic EPS | (0.78) | (0.50) | (0.46) | (0.63) | (0.58) | (0.71) | 9.60 | (2.78) |
| Diluted EPS | (0.78) | (0.50) | (0.46) | (0.63) | (0.58) | (0.71) | 9.60 | (2.78) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | (22.62) | (20.21) | (18.30) | (21.54) | (17.43) | (22.68) | (16.04) | (38.64) |
| Capital Expenditures | 0.90 | 0.44 | 0.79 | 0.40 | 0.71 | 0.03 | 0.09 | 0.78 |
| Free Cash Flow* | (23.52) | (20.64) | (19.09) | (21.93) | (18.14) | (22.71) | (16.13) | (39.43) |
| Investing Cash Flow | 29.21 | (97.10) | (129.97) | 17.06 | 25.99 | 3.23 | (67.34) | (93.25) |
| Financing Cash Flow | 2.32 | 87.44 | 0.44 | 187.82 | 1.33 | 0.00 | (0.13) | 234.24 |
← Scroll for more columns →
* Derived from reported values